Healthcare Services Group, Inc.

DB:HS1 Stock Report

Market Cap: €810.5m

Healthcare Services Group Valuation

Is HS1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HS1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HS1 (€10.7) is trading below our estimate of fair value (€48.8)

Significantly Below Fair Value: HS1 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HS1?

Key metric: As HS1 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for HS1. This is calculated by dividing HS1's market cap by their current earnings.
What is HS1's PE Ratio?
PE Ratio16.5x
EarningsUS$51.06m
Market CapUS$843.58m

Price to Earnings Ratio vs Peers

How does HS1's PE Ratio compare to its peers?

The above table shows the PE ratio for HS1 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11.4x
CWC CEWE Stiftung KGaA
11.1x2.2%€712.1m
GBF Bilfinger
7.6x2.2%€1.7b
BFSA Befesa
15.1x29.6%€838.4m
AAD Amadeus FiRe
11.9x7.2%€415.6m
HS1 Healthcare Services Group
16.5x16.2%€843.6m

Price-To-Earnings vs Peers: HS1 is expensive based on its Price-To-Earnings Ratio (16.5x) compared to the peer average (11.4x).

Price to Earnings Ratio vs Industry

How does HS1's PE Ratio compare vs other companies in the European Commercial Services Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
HS1 16.5xIndustry Avg. 13.6xNo. of Companies15PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: HS1 is expensive based on its Price-To-Earnings Ratio (16.5x) compared to the European Commercial Services industry average (13.6x).

Price to Earnings Ratio vs Fair Ratio

What is HS1's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HS1 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.5x
Fair PE Ratio11.2x

Price-To-Earnings vs Fair Ratio: HS1 is expensive based on its Price-To-Earnings Ratio (16.5x) compared to the estimated Fair Price-To-Earnings Ratio (11.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HS1 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€10.70
€13.12
+22.6%
13.6%€16.40€11.58n/a5
Dec ’25€11.50
€12.70
+10.4%
14.9%€15.70€11.08n/a4
Nov ’25€9.95
€12.70
+27.6%
14.9%€15.70€11.08n/a4
Oct ’25€9.90
€13.14
+32.7%
12.5%€15.67€11.06n/a4
Sep ’25€9.65
€13.14
+36.1%
12.5%€15.67€11.06n/a4
Aug ’25€10.40
€13.14
+26.3%
12.5%€15.67€11.06n/a4
Jul ’25€9.70
€13.52
+39.4%
11.4%€15.86€12.13n/a4
Jun ’25€9.75
€13.52
+38.7%
11.4%€15.86€12.13n/a4
May ’25€10.00
€13.52
+35.2%
11.4%€15.86€12.13n/a4
Apr ’25€11.40
€13.46
+18.1%
11.4%€15.78€12.07n/a4
Mar ’25€11.60
€13.46
+16.1%
11.4%€15.78€12.07n/a4
Feb ’25€8.60
€11.72
+36.3%
18.7%€14.71€9.20n/a4
Jan ’25€9.25
€11.72
+26.7%
18.7%€14.71€9.20n/a4
Dec ’24€8.80
€11.72
+33.2%
18.7%€14.71€9.20€11.504
Nov ’24€8.85
€12.79
+44.5%
16.1%€15.16€9.47€9.954
Oct ’24€9.90
€14.74
+48.9%
9.4%€16.85€13.10€9.904
Sep ’24€10.60
€14.22
+34.2%
8.7%€16.41€12.77€9.655
Aug ’24€11.40
€14.22
+24.8%
8.7%€16.41€12.77€10.405
Jul ’24€13.70
€14.88
+8.6%
8.3%€16.33€12.70€9.705
Jun ’24€12.70
€14.88
+17.2%
8.3%€16.33€12.70€9.755
May ’24€14.20
€14.88
+4.8%
8.3%€16.33€12.70€10.005
Apr ’24€12.90
€14.25
+10.5%
10.4%€16.73€13.01€11.406
Mar ’24€12.40
€13.48
+8.7%
21.0%€16.83€7.95€11.606
Feb ’24€12.30
€12.97
+5.5%
21.3%€17.19€8.12€8.606
Jan ’24€11.30
€12.97
+14.8%
21.3%€17.19€8.12€9.256
Dec ’23€13.20
€15.28
+15.8%
30.0%€24.33€8.62€8.807

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 10:58
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Healthcare Services Group, Inc. is covered by 18 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew WittmannBaird
William SutherlandBenchmark Company
James TerwilligerBenchmark Company